Virtus Fund Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Virtus Fund Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$393K	Buy	+11,580	New	+$330K	﹤0.01%	358
2015 Q2	–	Sell	-15,650	Closed	-$684K	–	893
2015 Q1	$684K	Sell	15,650 -1,455	-9%	-$67.6K	0.01%	372
2014 Q4	$594K	Buy	17,105 +83	+0.5%	+$3.37K	﹤0.01%	397
2014 Q3	$713K	Sell	17,022 -1,755	-9%	-$78.4K	0.01%	412
2014 Q2	$1.1M	Buy	+18,777	New	+$1.18M	0.01%	438

Other funds holding ARNA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtus Fund Advisers's ARNA Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q4 2017: 11,580 shares worth $393K. The stake represents ﹤0.01% of the portfolio and ranks #358 among its holdings. This is a return to the name: Virtus Fund Advisers previously reported a position in ARNA as recently as Q1 2015.

Virtus Fund Advisers first reported a position in ARNA in Q2 2014 and has held it in 5 quarters since. The position peaked at $1.1M in Q2 2014. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

Virtus Fund Advisers held 11,580 shares of Arena Pharmaceuticals Inc worth $393K as of Q4 2017.
Arena Pharmaceuticals Inc was a new Virtus Fund Advisers position in Q4 2017.
Arena Pharmaceuticals Inc made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #358 holding.
Virtus Fund Advisers first reported a position in Arena Pharmaceuticals Inc in Q2 2014 and has held it in 5 quarters since.
Virtus Fund Advisers's Arena Pharmaceuticals Inc position peaked at $1.1M in Q2 2014.
125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.